1531 - 1540 of 8137 Results
Title
Year
-
RESTRICTEDTitle: Diagnosis and Medical Management of Parkinson DiseaseJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page: 1281End Page: 1300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001152Citation Count: 3
-
RESTRICTEDTitle: Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy BodiesJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page: 1314End Page: 1332Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001151Citation Count: 5
-
OPENTitle: ECTRIMS 2022 – PosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 3_supplStart Page: 130End Page: 691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585221123687Best OA location URL: https://lirias.kuleuven.be/bitstream/20.500.12942/704893/2/poster_ECTRIMS_RIMS_Oct%202022_Peeters.pdfCitation Count: 18
-
RESTRICTEDTitle: Emerging therapeutic developments in neurodegenerative diseases: A clinical investigationJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 27Issue #: 10Start Page: 103305End Page: 103305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.drudis.2022.06.005Citation Count: 11
-
RESTRICTEDTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 33
-
OPENTitle: Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control StudyJournal Name: Clinical EpidemiologyPublisher: Informa UK LimitedVol: Volume 14Issue #:Start Page: 1217End Page: 1227Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/clep.s381289Best OA location URL: https://www.dovepress.com/getfile.php?fileID=84998Citation Count: 9
- Issue Overview2022RESTRICTEDTitle: Issue OverviewJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000892540.33029.c0Citation Count: 0
-
OPENTitle: Mechanisms controlling selective elimination of damaged lysosomesJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 29Issue #:Start Page: 100590End Page: 100590Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2022.100590Best OA location URL: https://doi.org/10.1016/j.cophys.2022.100590Citation Count: 16
-
RESTRICTEDTitle: Mechanisms of NLRP3 activation and pathology during neurodegenerationJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 151Issue #:Start Page: 106273End Page: 106273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2022.106273Citation Count: 10
-
RESTRICTEDTitle: Neurodegenerative Cerebellar AtaxiaJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page: 1409End Page: 1434Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001180Citation Count: 6